Medial Pharma spol.s.r.o.

Hradec Králové 500 12

0 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease — Completed
• A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease — Completed